Latigo Biotherapeutics Inc.

Musculoskeletal Disorders

Latigo Biotherapeutics Inc. is engaged in clinical research focused on osteoarthritis of the knee, with attention to conditions that affect joint function, mobility, and chronic pain.

  • Knee osteoarthritis
  • Joint pain
  • Mobility impairment

The sponsor’s clinical activity reflects interest in therapeutic options for degenerative joint disease and the management of symptoms associated with articular cartilage deterioration.

Pain Management

Its research portfolio includes evaluation of treatments intended to address pain linked to osteoarthritis, highlighting a therapeutic focus on symptom relief in chronic musculoskeletal disease.

  • Chronic pain
  • Analgesic therapy
  • Inflammatory pain

This area is centered on improving control of persistent discomfort that can limit daily activity and physical function in patients with knee joint disease.

Inflammatory Joint Conditions

The sponsor also shows interest in therapies for joint disorders where inflammation and structural degeneration contribute to ongoing symptoms and reduced quality of movement.

  • Synovial inflammation
  • Degenerative joint disease
  • Functional limitation

Clinical work in this field supports investigation of approaches relevant to the broader treatment of musculoskeletal inflammation and its impact on joint health.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A Study Testing How Well LTG-001 Works and Its Safety in Patients with Knee Osteoarthritis

    Not yet recruiting

    Investigated drugs:
    Denmark